Evidence map›Paper›PMID 30342116›Full record

ArticleJournal of hepatology2019

NK-cell responses are biased towards CD16-mediated effector functions in chronic hepatitis B virus infection.

Anita Schuch, Britta Franziska Zecher, Philipp Andreas Müller, Margareta P Correia, Franziska Daul, Charlotte Rennert, Catrin Tauber, Karolin Schlitt, Tobias Boettler, Christoph Neumann-Haefelin and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. [Advances in liver immunology in 2018].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2019
    Article
  17. HCMV jogs the 'memory' of NK cells in HBV.Journal of hepatology · 2019
    Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Anita SchuchDepartment of Medicine II, University Hospital Freiburg - Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, Freiburg 79106, Germany; Faculty of Biology, University of Freiburg, Schänzlestraße 1, Freiburg 79104, Germany.
Britta Franziska ZecherDepartment of Medicine II, University Hospital Freiburg - Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, Freiburg 79106, Germany.
Philipp Andreas MüllerDepartment of Medicine II, University Hospital Freiburg - Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, Freiburg 79106, Germany.
Margareta P CorreiaInnate Immunity Group, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Franziska DaulDepartment of Medicine II, University Hospital Freiburg - Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, Freiburg 79106, Germany; Faculty of Biology, University of Freiburg, Schänzlestraße 1, Freiburg 79104, Germany.
Charlotte RennertDepartment of Medicine II, University Hospital Freiburg - Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, Freiburg 79106, Germany.
Catrin TauberDepartment of Medicine II, University Hospital Freiburg - Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, Freiburg 79106, Germany; Faculty of Biology, University of Freiburg, Schänzlestraße 1, Freiburg 79104, Germany.
Karolin SchlittDepartment of Medicine II, University Hospital Freiburg - Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, Freiburg 79106, Germany.
Tobias BoettlerDepartment of Medicine II, University Hospital Freiburg - Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, Freiburg 79106, Germany.
Christoph Neumann-HaefelinDepartment of Medicine II, University Hospital Freiburg - Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, Freiburg 79106, Germany.
Hartmut HengelInstitute of Virology, University Hospital Freiburg - Faculty of Medicine, University of Freiburg, Hermann-Herder-Straße 11, Freiburg 79104, Germany.
Hanspeter PircherInstitute for Immunology, University Hospital Freiburg - Faculty of Medicine, University of Freiburg, Hermann-Herder-Straße 11, Freiburg 79104, Germany.
Adelheid CerwenkaInnate Immunity Group, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Department of Immunobiochemistry, University of Heidelberg, Medical Faculty Mannheim, Ludolf-Krehl-Strasse 13-17, Mannheim 68167, Germany.
Robert ThimmeDepartment of Medicine II, University Hospital Freiburg - Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, Freiburg 79106, Germany.
Maike HofmannDepartment of Medicine II, University Hospital Freiburg - Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, Freiburg 79106, Germany. Electronic address: maike.hofmann@uniklinik-freiburg.de.
University of Freiburg · DEGerman Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

aimsPhenotypic and functional natural killer (NK)-cell alterations are well described in chronic hepatitis B virus (cHBV) infection. However, it is largely unknown whether these alterations result from general effects on the overall NK-cell population or the emergence of distinct NK-cell subsets. Human cytomegalovirus (HCMV) is common in cHBV and is associated with the emergence of memory-like NK cells. We aimed to assess the impact of these cells on cHBV infection.

methodsTo assess the impact of memory-like NK cells on phenotypic and functional alterations in cHBV infection, we performed in-depth analyses of circulating NK cells in 52 patients with cHBV, 45 with chronic hepatitis C virus infection and 50 healthy donors, with respect to their HCMV serostatus.

resultsIn patients with cHBV/HCMV+, FcεRIγ- memory-like NK cells were present in higher frequencies and with higher prevalence than in healthy donors with HCMV+. This pronounced HCMV-associated memory-like NK-cell expansion could be identified as key determinant of the NK-cell response in cHBV infection. Furthermore, we observed that memory-like NK cells consist of epigenetically distinct subsets and exhibit key metabolic characteristics of long-living cells. Despite ongoing chronic infection, the phenotype of memory-like NK cells was conserved in patients with cHBV/HCMV+. Functional characteristics of memory-like NK cells also remained largely unaffected by cHBV infection with the exception of an increased degranulation capacity in response to CD16 stimulation that was, however, detectable in both memory-like and conventional NK cells.

conclusionsThe emergence of HCMV-associated memory-like NK cells shapes the overall NK-cell response in cHBV infection and contributes to a general shift towards CD16-mediated effector functions. Therefore, HCMV coinfection needs to be considered in the design of immunotherapeutic approaches that target NK cells in cHBV. LAY SUMMARY: In chronic hepatitis B virus infection, natural killer (NK)-cell phenotype and function is altered. In this study, we demonstrate that these changes are linked to the emergence of a distinct NK-cell subset, namely memory-like NK cells. The emergence of these memory-like NK cells is associated with coinfection of human cytomegalovirus that affects the majority of patients with chronic hepatitis B.

Indexed as

Cytomegalovirus InfectionsHepatitis B, ChronicLymphocyte SubsetsAdaptive ImmunityCoinfectionFemaleHumansImmunologic MemoryKiller Cells, NaturalLymphocyte ActivationMaleMiddle AgedReceptors, IgGReceptors, IgGAdaptiveCD16Chronic hepatitis B virus infectionHuman cytomegalovirusMemory-likeNK cells

Identifiers

PMID30342116
OpenAlexW2896939093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.